Русский / English
Enter the query
News
Press Center
phone: +7 495 785 29 07
fax: +7 499 230 32 94
press@interros.ru
Contacts
Building on the success of Rosa Khutor resort, the $1 bln project will bring quality hotels and rehabilitation facilities, new skiing tracks for over a million of visitors per year while creating thousands of new jobs More Topics Interros / VEB.RF / Vasta Discovery / Sochi
18.06.2021
Interros has not applied for the buyback of its Norilsk Nickel shares. As a result of the buyback, Interros share in Norilsk Nickel will increase, which is in line with our long-term strategy.
More Topics Interros / Norilsk Nickel / buyback
22.07.2020
A Russian original medication called Polyoxidonium® by Petrovax, a pharmaceutical company affiliated to the Interros Group, has passed the first phase of an international clinical trial for its effectiveness and safety for COVID-19 treatment.
More Topics Petrovax Pharm
17.04.2020
Polyoxidonium (azoximer bromide) - the Russian original drug produced by Petrovax-  was approved by the Ministry of Health of the Russian Federation for conducting an international clinical trial for the treatment of COVID-19.
More Topics Petrovax Pharm
25.10.2019
The common take-away was that «to become nature lovers, people need to have access to nature». Thus, the number one task is to create a legislative framework, currently all but non-existent.
More Topics Interros / Sustainable tourism / ecotourism / nature tourism / Rosa Khutor